Amino Science Labs sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.
🔥 FREE SHIPPING ON ORDERS OVER $250 🔥
Research Peptide
AOD 9604 is a synthetic 16-amino acid peptide fragment derived from the C-terminal region (amino acids 176-191) of human growth hormone. Research demonstrates AOD 9604 significantly enhances lipolytic activity and reduces body weight gain by upregulating beta-3 adrenergic receptors in adipose tissue. In clinical trials involving 925 participants, AOD 9604 increased fat metabolism without affecting insulin sensitivity, glucose tolerance, or IGF-1 levels. Studies show AOD 9604 reduces body weight by 1.8-2.6 kg more than placebo over 12 weeks while demonstrating excellent safety and tolerability profiles. The peptide promotes cartilage regeneration in osteoarthritis models and enhances joint repair when combined with hyaluronic acid, with no serious adverse events related to treatment across multiple controlled trials.
Fast shipping
Same-day dispatch
Third-party tested
U.S. accredited labs
99%+ purity
HPLC verified
16AA
SEQUENCE
hGH fragment 177-191 with Tyr
Lipolysis
MECHANISM
Stimulates fat breakdown
30+
PUBLICATIONS
In obesity & metabolism research
No IGF-1
EFFECT
Does not increase IGF-1 levels
1817Da
MOL. WEIGHT
C-terminal GH fragment
Free shipping
on orders over $150
Quality guarantee
99%+ purity verified
Secure checkout
256-bit SSL encryption
Research
AOD-9604 is a synthetic 16-amino-acid peptide that corresponds to the C-terminal fragment (residues 176–191) of the human growth hormone molecule, with a tyrosine added at the N-terminus to stabilize the sequence. Because it reproduces only this terminal region rather than the full hormone, it is studied in the research literature as a metabolic peptide fragment distinct from intact growth hormone. Cataloged under CAS 221231-10-3 with the molecular formula C78H123N23O23S2 and an average mass near 1815 Da, this 5 mg presentation is supplied as a lyophilized reference material for in-vitro and preclinical laboratory research use only.
Investigational interest in AOD-9604 stems from how a short C-terminal hGH fragment behaves in adipose and metabolic model systems while lacking the full-length hormone's growth-signaling domains. The compound has no established consumer application, and the surrounding body of work remains preliminary and ongoing. Data generated in cell-based and animal-model systems characterize the material's laboratory behavior and should not be extrapolated to human or animal outcomes.
Reported experimental work with AOD-9604 has centered on lipid-metabolism model systems. Datasets in the published preclinical record have examined the fragment's association with adipose-tissue lipolytic activity and reported changes in beta-3 adrenergic receptor expression in fat-cell models. A recurring observation described across these studies is that measured signals on fat-metabolism endpoints were reported without corresponding changes to insulin sensitivity, glucose tolerance, or circulating IGF-1 in the model systems examined, a profile the literature contrasts with that of intact growth hormone. These are descriptions of experimental observations in laboratory systems, not statements of effect in humans or animals.
Separate lines of investigation have used AOD-9604 in cartilage-model and joint-repair systems, where it has been studied alone and in combination with hyaluronic acid as a matrix component. These descriptions summarize laboratory research observations only and do not establish safety, efficacy, or any outcome for any use.
The studies referenced here describe experimental research findings in laboratory systems, not consumer outcomes. They are not medical claims, do not establish safety or efficacy for any use, and must not be interpreted as guidance for administration to humans or animals. This material is for in-vitro laboratory research only, and nothing on this page constitutes medical advice.
Each research lot of AOD-9604 is supplied as a lyophilized powder characterized to ≥98% purity before release. Identity and purity are established with orthogonal analytical methods so that the Certificate of Analysis (COA) reflects both how much of the sample is the target 16-residue peptide and confirmation that the target molecule is correct. Because AOD-9604 contains two cysteine-derived sulfur atoms (reflected in the S2 of its formula), mass and disulfide-state verification are a meaningful part of identity confirmation.
The COA tied to the specific lot number received is the definitive analytical record for that material. Because purity and measured mass can vary slightly between synthesis batches, researchers documenting experimental inputs should cite the lot-specific COA rather than generic specifications, and retain it alongside experimental records to support reproducibility and traceability.
AOD-9604 is a synthetic 16-amino-acid peptide corresponding to the C-terminal fragment (residues 176–191) of human growth hormone, with an added N-terminal tyrosine for stability. It reproduces only this terminal region rather than the full hormone, and in the research literature it is studied as a distinct metabolic fragment. It is supplied strictly as a lyophilized reference material for in-vitro laboratory research.
It ships as a lyophilized (freeze-dried) powder in a sealed vial containing 5 mg of peptide. Lyophilization supports shelf stability for a research peptide and allows the sample to be reconstituted with a solvent of the researcher's choice under standard aseptic laboratory technique when preparing in-vitro experiments. Refer to the storage table on this page for temperature and stability windows.
Purity is measured by reversed-phase HPLC and reported as a percentage of total peak area (≥98%), while identity is confirmed by mass spectrometry (ESI-MS or MALDI-TOF) against the theoretical mass (~1815 Da) for the C78H123N23O23S2 sequence. The lot-specific COA documents both values plus appearance and net peptide content, and is the authoritative record for the exact material received.
Published work is predominantly adipose-metabolism and joint-model in nature, spanning lipolytic-pathway activity, beta-3 adrenergic receptor expression in fat-cell systems, metabolic-marker panels (glucose, insulin, IGF-1), and cartilage/joint-repair models including combinations with hyaluronic acid. This research is preliminary and ongoing, describes laboratory research systems only, and does not establish any consumer outcome or constitute medical advice.
This product is sold strictly for in-vitro research and laboratory use only. It is not intended for human or animal consumption, diagnostic purposes, or therapeutic application.
By purchasing this product, you confirm that you are a qualified researcher operating within an appropriate laboratory environment and will use this compound in accordance with all applicable local, state, and federal regulations.
Amino Science Labs assumes no liability for misuse of this product outside of its intended research application.
The S2 in C78H123N23O23S2 reflects two cysteine-derived sulfur atoms in the sequence, which can form a disulfide linkage. This makes mass confirmation and disulfide-state verification a meaningful part of identity checks, and it is one reason mass spectrometry is used alongside HPLC purity analysis when characterizing each lot.
No. This material is supplied strictly for in-vitro and laboratory research use by qualified researchers. It is not a drug, supplement, or food, is not intended for human or animal consumption or any diagnostic or therapeutic purpose, and nothing on this page constitutes medical advice.
